Hawksbill Pharmaceuticals Private Limited

Hawksbill Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2021PTC120020 Incorporated 05 February 2021 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Revenue · FY 2025
₹52.1 Lakh
▲ 9% YoY
Net profit · FY 2025
₹1.6 Lakh
Net margin 3.1%
EBITDA · FY 2025
₹4.74 Lakh
EBITDA margin 9.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹75,000
Issued & subscribed
Open charges
₹26 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings

About Hawksbill Pharmaceuticals Private Limited

Data last updated:

Hawksbill Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2021PTC120020. Its GSTIN is 24AAFCH6465G1ZJ (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹75,000. It is led by directors including Aahna Sinha and Astha Sinha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 401 Lake View Tower Opp. Vastrapur Lake Vastrapur, Ahmedabad, Gujarat, India – 380015.

As per the financials filed for FY 2025, the company reported a revenue of ₹52.1 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.6 Lakh (net margin 3.1%) and EBITDA of ₹4.74 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.

As per MCA filings, the company has open charges of ₹26 Lakh on record.

Hawksbill Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0063384).

Company details

CIN U24230GJ2021PTC120020
Registration Number 120020
Incorporation Date 05 February 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0063384

Recognitions & Rankings of Hawksbill Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-GJ-01-0063384

Contact details

Hawksbill Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 401 Lake View Tower Opp. Vastrapur Lake Vastrapur, Ahmedabad, Gujarat, India – 380015
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Hawksbill Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hawksbill Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Financials of Hawksbill Pharmaceuticals Private Limited

FY 2025 filings available

Hawksbill Pharmaceuticals Private Limited reported revenue of ₹52.1 Lakh (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹52.1 Lakh ▲ 9%
Net profit · FY 2025
₹1.6 Lakh margin 3.1%
EBITDA · FY 2025
₹4.74 Lakh margin 9.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 116%

Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 9% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.6 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.1%
Net Profit Margin3.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Board of directors of Hawksbill Pharmaceuticals Private Limited

Hawksbill Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aahna SinhaDirector21 Aug 20233 Years 3 MonthsCurrent
Astha SinhaDirector21 Aug 20233 Years 3 MonthsCurrent
Bishwas Kumar SinhaDirector05 Feb 20215 Years 9 MonthsCurrent

Peer comparison

Hawksbill Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Fab Biotech Private Limited₹52.26 Lakh (FY 2025)-24.0%Greater Noida, Uttar Pradesh, India
Hawksbill Pharmaceuticals Private Limitedthis company₹52.1 Lakh (FY 2025)₹1.6 Lakh3.1%9.0%Ahmedabad, Gujarat, India
Prochem Bioceuticals Private Limited₹52.07 Lakh (FY 2025)-13.0%Delhi, India
Myriad Pharmaceuticals Private Limited₹52.03 Lakh (FY 2025)10.0%Nagpur, Maharashtra, India
Bioziv Healthcare Private Limited₹51.99 Lakh (FY 2024)-23.0%Manimajra, Chandigarh, India

To see the full peer comparison of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Auditor

Hawksbill Pharmaceuticals Private Limited is audited by Manjot Sachdev & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Manjot Sachdev & AssociatesFY 2023029529N

Shareholding

The shareholding of Hawksbill Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹26 Lakh
Satisfied charges
None
Breakdown by lending institutions
Indian Overseas Bank₹0.26 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Sep 2023100799541Indian Overseas Bank₹18 LakhOpen
31 Mar 2022100565038Indian Overseas Bank₹8 LakhOpen

To see the full charge records of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hawksbill Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Hawksbill Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.

Active EPFO establishments
1

GST

Hawksbill Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AAFCH6465G1ZJGujaratActive22 Feb 2021
05AAFCH6465G1ZJUttarakhandActive18 Apr 2021

To see the full GST registrations and return filing status of Hawksbill Pharmaceuticals Private Limited, buy the company report.

Recent activity

Hawksbill Pharmaceuticals Private Limited has 7 board changes on record since 2021: 3 appointments and 4 cessations. The latest: Aahna Sinha ceased to be Additional Director on 29 Sep 2023.

AGM
Hawksbill Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hawksbill Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Indian Overseas Bank of Rs. 18.00 Lakh registered on 27 Sep 2023 with Charge ID 100799541 was modified on 30 Nov 2024.
Ceased
Aahna Sinha ceased to be Additional Director.
Ceased
Astha Sinha ceased to be Additional Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 18.00 Lakh with Charge ID 100799541 was registered on 27 Sep 2023.
Ceased
Subodh Kumar ceased to be Director.
Appointed
Aahna Sinha was appointed as Director.
Appointed
Astha Sinha was appointed as Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 8.00 Lakh with Charge ID 100565038 was registered on 31 Mar 2022.
Ceased
Amit Jaiswal ceased to be Director.
Appointed
Bishwas Kumar Sinha was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Hawksbill Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 February 2021 (5+ years old) and is registered under CIN U24230GJ2021PTC120020.

Hawksbill Pharmaceuticals has 3 current directors:

The latest financial statements of Hawksbill Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Hawksbill Pharmaceuticals is 24AAFCH6465G1ZJ, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAFCH6465G1ZJ (Uttarakhand).

The CIN (Corporate Identification Number) of Hawksbill Pharmaceuticals is U24230GJ2021PTC120020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hawksbill Pharmaceuticals was incorporated on 05 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Hawksbill Pharmaceuticals by revenue are Fab Biotech Private Limited, Prochem Bioceuticals Private Limited, Myriad Pharmaceuticals Private Limited, Bioziv Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Aahna Sinha ceased to be Additional Director on 29 Sep 2023. Astha Sinha ceased to be Additional Director on 29 Sep 2023. Subodh Kumar ceased to be Director on 12 Sep 2023. Hawksbill Pharmaceuticals has 7 board changes on record in total.

Yes, Hawksbill Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Hawksbill Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0063384).

The registered office of Hawksbill Pharmaceuticals is at B – 401 Lake View Tower Opp. Vastrapur Lake Vastrapur, Ahmedabad, Gujarat, India – 380015.